Citigroup’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.22M Sell
52,533
-20,992
-29% -$2.89M ﹤0.01% 1186
2025
Q1
$13.3M Sell
73,525
-26,108
-26% -$4.71M 0.01% 865
2024
Q4
$15.6M Buy
99,633
+64,549
+184% +$10.1M 0.01% 763
2024
Q3
$6.39M Buy
35,084
+13,874
+65% +$2.53M ﹤0.01% 1177
2024
Q2
$3.9M Sell
21,210
-30,908
-59% -$5.68M ﹤0.01% 1322
2024
Q1
$9.27M Buy
52,118
+15,552
+43% +$2.77M 0.01% 927
2023
Q4
$4.54M Buy
36,566
+779
+2% +$96.6K ﹤0.01% 1181
2023
Q3
$4.15M Buy
35,787
+13,423
+60% +$1.56M ﹤0.01% 1128
2023
Q2
$2.63M Sell
22,364
-28,221
-56% -$3.31M ﹤0.01% 1488
2023
Q1
$4.05M Buy
50,585
+21,825
+76% +$1.75M ﹤0.01% 1205
2022
Q4
$2.28M Sell
28,760
-21,063
-42% -$1.67M ﹤0.01% 1428
2022
Q3
$3.47M Buy
49,823
+12,806
+35% +$892K ﹤0.01% 1285
2022
Q2
$2.43M Buy
37,017
+21,785
+143% +$1.43M ﹤0.01% 1475
2022
Q1
$1.01M Sell
15,232
-19,656
-56% -$1.31M ﹤0.01% 2314
2021
Q4
$2.44M Buy
34,888
+4,926
+16% +$345K ﹤0.01% 1819
2021
Q3
$1.56M Sell
29,962
-19,413
-39% -$1.01M ﹤0.01% 2077
2021
Q2
$3.36M Buy
49,375
+10,456
+27% +$711K ﹤0.01% 1733
2021
Q1
$3M Buy
38,919
+17,244
+80% +$1.33M ﹤0.01% 1681
2020
Q4
$1.3M Buy
21,675
+19,943
+1,151% +$1.2M ﹤0.01% 1984
2020
Q3
$75K Sell
1,732
-32,489
-95% -$1.41M ﹤0.01% 3283
2020
Q2
$1.42M Sell
34,221
-25,488
-43% -$1.06M ﹤0.01% 1860
2020
Q1
$2.58M Sell
59,709
-1,060
-2% -$45.8K ﹤0.01% 1250
2019
Q4
$3.37M Buy
60,769
+46,937
+339% +$2.6M ﹤0.01% 1324
2019
Q3
$481K Buy
13,832
+11,377
+463% +$396K ﹤0.01% 2598
2019
Q2
$99K Sell
2,455
-19,659
-89% -$793K ﹤0.01% 3639
2019
Q1
$728K Buy
22,114
+11,811
+115% +$389K ﹤0.01% 2206
2018
Q4
$214K Buy
+10,303
New +$214K ﹤0.01% 3055